RECURRENT LUNG NON-SMALL CELL CARCINOMA
Clinical trials for RECURRENT LUNG NON-SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT LUNG NON-SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT LUNG NON-SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough lung cancers: trial tests combo after other treatments fail
Disease control Not yet recruitingThis study is for people with advanced non-small cell lung cancer that has spread or come back and has gotten worse despite receiving standard chemotherapy and immunotherapy. It tests whether combining an experimental pill called SX-682 with an existing immunotherapy drug (atezol…
Matched conditions: RECURRENT LUNG NON-SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New Two-Pronged attack on tough lung cancers shows promise
Disease control Not yet recruitingThis study is for people with advanced non-small cell lung cancer that has specific gene changes and has stopped responding to prior treatments. It will test whether two newer targeted drugs, given alone or together, can control the cancer better than standard options. The goal i…
Matched conditions: RECURRENT LUNG NON-SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC